Investing IdeasBrowse All StocksMarkets

Have your own idea? Try our Stock Screener

Header cover image

Swedish (OMX) Clinical Research and Equipment Industry Analysis

UpdatedOct 07, 2024
DataAggregated Company Financials
Companies11
  • 7D-2.5%
  • 3M7.2%
  • 1Y80.7%
  • YTDn/a

Over the last 7 days, the Clinical Research and Equipment industry has dropped 2.4%, driven by AddLife declining 2.2%. Meanwhile, Magle Chemoswed Holding actually outperformed within the industry, gaining 6.7% in the last week. Over the past 12 months, the industry was up 81%. Looking forward, earnings are forecast to grow by 49% annually.

Industry Valuation and Performance

Has the Swedish Clinical Research and Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 07 Oct 2024SEK 47.2bSEK 16.7b-SEK 988,175,491.0058.9x-47.7x2.8x
Wed, 04 Sep 2024SEK 48.6bSEK 16.7b-SEK 987,374,492.0061.8x-49.2x2.9x
Fri, 02 Aug 2024SEK 49.2bSEK 16.7b-SEK 1,128,120,510.0061.9x-43.6x2.9x
Sun, 30 Jun 2024SEK 42.0bSEK 16.3b-SEK 1,188,686,510.0055.3x-35.3x2.6x
Tue, 28 May 2024SEK 43.1bSEK 16.3b-SEK 1,188,686,510.0061.1x-36.2x2.6x
Thu, 25 Apr 2024SEK 37.9bSEK 16.1b-SEK 1,234,732,213.0036.3x-30.7x2.4x
Sat, 23 Mar 2024SEK 38.9bSEK 16.0b-SEK 1,122,792,210.0036x-34.6x2.4x
Mon, 19 Feb 2024SEK 41.0bSEK 16.0b-SEK 1,409,735,350.0050.7x-29.1x2.6x
Wed, 17 Jan 2024SEK 36.9bSEK 15.5b-SEK 1,393,723,683.0045.2x-26.5x2.4x
Fri, 15 Dec 2023SEK 37.4bSEK 15.5b-SEK 1,393,723,683.0046.1x-26.8x2.4x
Sun, 12 Nov 2023SEK 31.2bSEK 15.4b-SEK 1,256,647,710.0034x-24.8x2x
Tue, 10 Oct 2023SEK 25.6bSEK 15.1b-SEK 1,134,516,711.0036.6x-22.6x1.7x
Thu, 07 Sep 2023SEK 29.6bSEK 15.1b-SEK 1,133,372,831.0036.6x-26.1x2x
Sat, 05 Aug 2023SEK 32.1bSEK 15.1b-SEK 213,871,038.0046.7x-150.2x2.1x
Mon, 03 Jul 2023SEK 36.5bSEK 14.6b-SEK 172,476,038.0036.1x-211.7x2.5x
Wed, 31 May 2023SEK 39.0bSEK 14.6b-SEK 173,602,038.0039.4x-224.6x2.7x
Fri, 28 Apr 2023SEK 35.0bSEK 14.5b-SEK 110,425,459.0034x-316.9x2.4x
Sun, 26 Mar 2023SEK 31.9bSEK 14.6b-SEK 57,185,459.0031x-557.6x2.2x
Tue, 21 Feb 2023SEK 41.8bSEK 14.4bSEK 826.4m36.4x50.6x2.9x
Thu, 19 Jan 2023SEK 40.3bSEK 14.2bSEK 943.9m38.7x42.7x2.8x
Sat, 17 Dec 2022SEK 39.4bSEK 14.1bSEK 944.3m41.5x41.7x2.8x
Mon, 14 Nov 2022SEK 40.0bSEK 14.1bSEK 936.8m42.1x42.7x2.8x
Wed, 12 Oct 2022SEK 32.4bSEK 13.5bSEK 750.9m47.2x43.1x2.4x
Fri, 09 Sep 2022SEK 37.5bSEK 13.5bSEK 751.3m54.5x49.9x2.8x
Sun, 07 Aug 2022SEK 43.7bSEK 13.2bSEK 667.8m44.6x65.4x3.3x
Tue, 05 Jul 2022SEK 43.4bSEK 13.2bSEK 753.4m39x57.6x3.3x
Thu, 02 Jun 2022SEK 54.8bSEK 13.2bSEK 753.4m48.2x72.8x4.1x
Sat, 30 Apr 2022SEK 53.3bSEK 12.7bSEK 742.5m51.9x71.8x4.2x
Mon, 28 Mar 2022SEK 60.7bSEK 11.8bSEK 746.3m53.5x81.3x5.1x
Wed, 23 Feb 2022SEK 50.6bSEK 11.4bSEK 784.8m43x64.5x4.4x
Fri, 21 Jan 2022SEK 69.2bSEK 10.8bSEK 786.3m46.9x88x6.4x
Sun, 19 Dec 2021SEK 79.5bSEK 10.8bSEK 786.3m51.5x101.1x7.4x
Tue, 16 Nov 2021SEK 88.7bSEK 10.8bSEK 788.5m54.4x112.4x8.2x
Thu, 14 Oct 2021SEK 91.2bSEK 9.9bSEK 853.6m54x106.9x9.2x
Price to Earnings Ratio

106.9x


Total Market Cap: SEK 91.2bTotal Earnings: SEK 853.6mTotal Revenue: SEK 9.9bTotal Market Cap vs Earnings and Revenue0%0%0%
Swedish Clinical Research and Equipment Industry Price to Earnings3Y Average -36.7x202220232024
Current Industry PE
  • Investors are pessimistic on the Swedish Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 3.4x is higher than the industry's current PS ratio of 2.8x.
Past Earnings Growth
  • Total earnings for the Life Sciences Tools and Services industry have declined over the last three years, with the industry now making a loss overall.
  • Meanwhile revenues have grown 19% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased, which has decreased profits.

Industry Comparison

How does Swedish Clinical Research and Equipment compare with similar industries?

SE Market-1.29%
Healthcare-2.45%
Life Sciences-2.48%
Clinical Research and Equipment-2.48%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
MAGLE Magle Chemoswed HoldingSEK 41.206.7%
+SEK 28.1m		39.2%PE57.8x
AROC AroCellSEK 0.523.0%
+SEK 3.5m		4.0%PS2.5x
PEXA B PExASEK 0.478.1%
+SEK 2.0m		16.7%PS20.6x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlansLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

ALIF B

SEK 158.40

AddLife

7D

-2.2%

1Y

141.1%

Does AddLife (STO:ALIF B) Have A Healthy Balance Sheet?

Oct 02
Does AddLife (STO:ALIF B) Have A Healthy Balance Sheet?

GENO

SEK 25.00

Genovis AB (publ.)

7D

-11.2%

1Y

-36.5%

MCAP

SEK 485.50

MedCap

7D

-3.7%

1Y

81.8%

BIOT

SEK 184.10

Biotage

7D

-0.8%

1Y

75.0%

Investors Interested In Biotage AB (publ)'s (STO:BIOT) Earnings

Sep 17
Investors Interested In Biotage AB (publ)'s (STO:BIOT) Earnings

BICO

SEK 42.50

BICO Group

7D

-4.5%

1Y

47.1%

PEXA B

SEK 0.47

PExA

7D

8.1%

1Y

16.7%

ATANA

SEK 0.037

Attana

7D

-52.6%

1Y

-83.3%

PRO

SEK 33.70

Promimic

7D

-6.6%

1Y

27.7%

AROC

SEK 0.52

AroCell

7D

3.0%

1Y

4.0%

MAGLE

SEK 41.20

Magle Chemoswed Holding

7D

6.7%

1Y

39.2%

LEVBIO

SEK 0.40

Level Bio

7D

-4.8%

1Y

-28.7%